Warning letter
Baxter Healthcare Corp. [ARCHIVED]: warning letter of Sep 10, 2009
FDA warning letter 59962 · Chicago District Office
Key facts
| Reference number | 59962 |
|---|---|
| Company | Baxter Healthcare Corp. [ARCHIVED] |
| Subject | Medical Devices/Adulterated/Misbranded |
| Issue date | Sep 10, 2009 |
| Posted date | Sep 10, 2009 |
| Issuing office | Chicago District Office |
| Product type | Biologics |
| CFR sections cited | 820 |
| Inspection city | Deerfield |
| Inspection ZIP | 60015 |
| Inspection start date | Apr 2, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: